The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.05 (0.55%)
Spread: 0.70 (7.955%)
Open: 9.10
High: 9.15
Low: 8.70
Prev. Close: 9.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of the open offer

4 Apr 2016 10:17

RNS Number : 0454U
Scancell Holdings Plc
04 April 2016
 

04 April 2016

 

Scancell Holdings Plc

("Scancell" or the "Company")

 

Result of the open offer

 

On 1 April 2016 the Board of Scancell announced that it had received subscriptions in respect of 16,048,593 new Ordinary Shares of the 22,495,068 new Ordinary Shares available under the Open Offer.

 

The Company has now received applications for an additional 558,823 new Ordinary Shares, available but not subscribed for by Qualifying Shareholders in the Open Offer, therefore the revised total subscription under the Open Offer is 16,607,416 new Ordinary Shares, representing 73.8 per cent. the new Ordinary Shares available under the Open Offer. The Company has therefore raised gross proceeds of approximately £2.8 million through the Open Offer and £3.4 million through the Placing being approximately £6.2 million in total.

 

Application will be made to the London Stock Exchange for the admission to trading on AIM of the 36,607,416 new Ordinary Shares to be issued under the Placing and Open Offer. It is expected that Admission will occur and that dealings will commence at 08:00 a.m. on 5 April 2016. The total number of Ordinary Shares following Admission will be 261,558,099 with each share carrying the right to one vote. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in Scancell under the FCA's Disclosure and Transparency Rules.

 

This announcement should be read in conjunction with the full text of the Circular posted to Shareholders on 11 March 2016, copies of which are available on the Company's website at www.scancell.co.uk. Capitalised terms not otherwise defined in this announcement have the meanings given in the Circular. 

 

 

For further information please contact:

 

Scancell Holdings Plc

Dr Richard Goodfellow, Joint CEO

Professor Lindy Durrant, Joint CEO

+44 (0) 20 3727 1000

Panmure Gordon (Nominated Adviser and placing agent)

Robert Naylor/Paul Fincham, Corporate Finance

Maisie Atkinson, Sales

+44 (0) 20 7886 2500

Lesmoir-Gordon, Boyle & Co. Limited (Sub placing agent)

Angus Grierson

+44 (0) 20 7518 9892

FTI Consulting

Mo Noonan

Simon Conway

+44 (0) 20 3727 1000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEMMGGDLDFGVZG
Date   Source Headline
12th Sep 20193:56 pmRNSResult of AGM
4th Sep 20197:00 amRNSFirst Collaboration Agreement for AvidiMab
20th Aug 20192:23 pmRNSNotice of AGM
20th Aug 20197:00 amRNSFinal Results for the year ended 30 April 2019
19th Aug 20197:00 amRNSUpdate on the SCIB1 Phase 2 clinical trial
7th Aug 20197:00 amRNSNotice of Final Results
1st Jul 20197:00 amRNSH1 2019 Business Update
18th Jun 20199:16 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSBoard Appointment
17th Jun 201910:45 amRNSHolding(s) in Company
14th Jun 20194:41 pmRNSSecond Price Monitoring Extn
14th Jun 20194:35 pmRNSPrice Monitoring Extension
13th Jun 20197:00 amRNSShare Subscription and Issue of Equity to Vulpes
29th May 201911:05 amRNSSecond Price Monitoring Extn
29th May 201911:00 amRNSPrice Monitoring Extension
20th May 20197:00 amRNSScancell and CRUK provide an update on SCIB2
10th May 20197:00 amRNSClinical Advisory Board and Update on Modi-1
25th Apr 20197:00 amRNSUK approval to start SCIB1 Phase 2 trial
8th Apr 20197:00 amRNSJapan patent for Moditope immunotherapy platform
21st Mar 20197:00 amRNSProfessor Lindy Durrant receives Waldenström award
20th Mar 20197:00 amRNSScancell strengthens IP portfolio
5th Mar 20196:27 pmRNSHolding(s) in Company
4th Mar 20194:40 pmRNSSecond Price Monitoring Extn
4th Mar 20194:35 pmRNSPrice Monitoring Extension
21st Feb 20197:00 amRNSChange of Auditor
31st Jan 20197:00 amRNSInterim Results
23rd Jan 20197:00 amRNSUpdate on Cancer Research UK's Grand Challenge
21st Jan 20197:00 amRNSAppoints Heads of Research and Manufacturing
12th Nov 20187:00 amRNSScancell to Present at Two Conferences
1st Nov 20187:00 amRNSScancell to present at Proactive Investors Forum
30th Oct 20185:18 pmRNSResults of AGM
30th Oct 20187:00 amRNSIdentification of 2nd Moditope Cancer Vaccine
24th Oct 20189:05 amRNSSecond Price Monitoring Extn
24th Oct 20189:00 amRNSPrice Monitoring Extension
24th Oct 20187:00 amRNSUpdate on SCIB1 Phase 2 Clinical Study
5th Oct 20187:00 amRNSNotice of AGM
25th Sep 20187:00 amRNSFinal Results for the year ended 30 April 2018
18th Sep 20187:00 amRNSNotice of Final Results
10th Aug 20187:00 amRNSBoard Change
9th Aug 20187:00 amRNSAgreement
25th Jul 20182:45 pmRNSDirector/PDMR Shareholding
24th Jul 20187:00 amRNSIssue of Equity
18th Jul 20187:00 amRNSScancell exercises TriGrid commercial option
23rd May 20187:00 amRNSGrant of European patent for Moditope platform
11th May 20181:11 pmRNSHolding(s) in Company
9th May 201810:12 amRNSHolding(s) in Company
8th May 20187:00 amRNSResult of the Open Offer and PDMR Shareholdings
23rd Apr 201812:43 pmRNSHolding(s) in Company
20th Apr 20184:32 pmRNSHolding(s) in Company
18th Apr 20182:29 pmRNSResult of Placing and Subscription and PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.